ICCM logo

ICCM IceCure Medical Ltd

NASDAQ Capital Market · Medical - Devices · Healthcare

$0.76
+0.03 (+4.12%)

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Market Cap: $1.71Mwww.icecure-medical.com

Price

No data yet.

Social Signal Score

52
5d
53
4 mentions
—
30d
52
6 mentions
—
60d
51
8 mentions
—
90d
52
9 mentions
—
news: 9

Analyst Ratings

3 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 0Sell 0Strong Sell 0
Avg price target$1+31.6%
Low $1Median $1High $1
Current Consensus

Revenue

$907.0K+346.61%
$58.3K$517.6K$976.8K$1.44M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$-6.90
$-8.03–$-6.28
1 analysts
FY2026
$-5.35
$-6.23–$-4.87
1 analysts
FY2027
$-3.66
$-4.26–$-3.33
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Eyal Shamir
Sector
Healthcare
Industry
Medical - Devices
Employees
68
Beta
0.43
Country
IL
Piotroski score
4 / 9 (Middling)
Altman Z-score
-12.20
www.icecure-medical.com